http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105796522-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate | 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105796522-B |
| titleOfInvention | Pulsatile release tablets containing fluticasone furoate and Vilantro and preparation method |
| abstract | The present invention provides the pulsatile release tablets of a kind of fluticasone furoate and Vilantro, which can reach blood concentration at midnight and early morning, to achieve the purpose that circadian therapy.The pulsatile release tablets include two parts of floating layer and label.Floating layer uses hydrophilic macromolecule and fatty alcohol for auxiliary material, when making it that can be detained regular hour tablet and gastric juice in stomach to contact, floating layer surface hydration, which forms gel, makes volume expansion, when less than gastric juice density, just drift is suspended from gastric content, with the bulk erosion of floating layer, expose label, to make drug be released from label. |
| priorityDate | 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.